Skip to main content
Premium Trial:

Request an Annual Quote

Luxembourg Center Taps Biobase to Analyze NGS Variants for Clinical Diagnostics

Premium

Biobase said this week that the Luxembourg Center for Systems Biomedicine will use its Genome Trax software to analyze next-generation sequencing data for use in clinical diagnostics.

Additionally, Biobase said that it will work with LCSB to establish “a hub of expertise” for the application of the company’s products and to provide data analysis, training, and support to researchers in Luxembourg and surrounding countries.

In a statement, Reinhard Schneider, who heads the bioinformatics core facility at LCSB, said that the mutation, regulation, and pharmacogenomics data in Genome Trax are “crucial for the annotation of our clinical data.”

He described LCSB’s collaboration with Biobase “as a strategic partnership to advance the clinical application of NGS technology."

Genome Trax helps users prioritize human genome variants in whole-genome or exome data. The tool maps NGS data to known features such as disease mutations and regulatory sites, allowing users identify novel mutations that could affect the function of candidate disease genes.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.